Cardiovascular Drug Use in the Elderly.

Area of Science:

• Geriatric Medicine
• Clinical Pharmacology
• Drug Safety

Background:

• Aging alters drug metabolism and response, increasing susceptibility to adverse drug events.
• Elderly individuals often use multiple medications (polypharmacy), elevating the risk of drug interactions.
• Cardiovascular drugs are commonly involved in adverse drug interactions within this population.

Purpose of the Study:

• To highlight the increased risk of adverse drug effects and interactions in the elderly.
• To identify factors contributing to these risks, including physiological changes and polypharmacy.
• To provide recommendations for minimizing adverse drug reactions in older patients.

Main Methods:

• Review of pharmacokinetic and pharmacodynamic changes associated with aging.
• Analysis of drug utilization patterns in the elderly, focusing on polypharmacy.
• Identification of frequently implicated drug classes, particularly cardiovascular agents.

Main Results:

• Physiological changes in aging significantly impact drug absorption, distribution, metabolism, and excretion.
• Polypharmacy in the elderly substantially increases the likelihood and severity of drug-drug interactions.
• Cardiovascular medications represent a major category associated with adverse drug interactions in older adults.

Conclusions:

• Adverse drug effects and interactions pose a significant threat to the health of elderly patients.
• Understanding age-related physiological changes and managing polypharmacy are crucial for drug safety.
• Implementing specific recommendations can help mitigate the risks of adverse drug reactions in geriatric populations.